Supportive Expressive Therapy for Depressed and Anxious Adolescents
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Depression
- Sponsor
- Centre for Addiction and Mental Health
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- BDI
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The purpose of the study is to investigate the effectiveness of providing Supportive Expressive Therapy to adolescents who are depressed and/or anxious.
Detailed Description
Supportive Expressive Therapy (SET; a 16 session manualized form of psychodynamic therapy) has been well utilized with adult clients. To date, there is no known systematic study into the benefit of this method of therapy with adolescents who are depressed and/or anxious. It is thought that SET would be useful for this population as it is similar in principle to Interpersonal Relationship Therapy (IPT), which has been shown to be effective for use with depressed adults and youth. Both IPT and SET help clients explore the role they play within challenging relationships in their lives. SET, however, allows for the exploration of more relationships within the adolescents' circle. Moreover, SET explores the adolescents' perceptions of themselves, others, and their wish in relationships. Further, the SET method is more easily individualized in that it affords greater flexibility in design and possibility for change over time. Accordingly, the purpose of this study is to explore the feasibility of utilizing this method of therapy with adolescents who are depressed and anxious. We will be exploring the effectiveness of SET through the resolution of depressed and/or anxious adolescents' conflictual relationships thereby reducing their symptomatology.
Investigators
Pamela Wilansky-Traynor
psychologist
Centre for Addiction and Mental Health
Eligibility Criteria
Inclusion Criteria
- •15-24 year old, male \& female adolescents, primary diagnosis of depression or anxiety disorder.
- •Clients with co-morbid diagnoses, suicidal ideation or taking medication would not necessarily be excluded if deemed able to partake in the proposed therapy.
- •Medication dose needs to be stable for 4-6 weeks prior to starting therapy.
Exclusion Criteria
- •Clients who are actively psychotic, developmentally delayed, or have a diagnosis of bipolar disorder.
- •Clients who are not fluent in English.
Outcomes
Primary Outcomes
BDI
Time Frame: pre and post
MASC
Time Frame: pre and post
Measures collected at pre, post, and follow-up
Time Frame: pre and post
Secondary Outcomes
- CBCL(pre and post)
- YSR(pre and post)
- FAM(pre and post)
- SSRS(pre and post)
- CRI(pre and post)
- Measures collected at pre, post, and follow-up(pre and post)